Impact Factor
3.23
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
1.60
4,236 total citations
h5-index
70
h5 depth signal
Cited share
28.8%
807 of 2,798
Total citations
4,236
Citation footprint
Metric signal
1.67
External metric anchor
Self-citation
4.7%
198 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
1,340
United Kingdom
1,172
Spain
1,023
China
1,013
Italy
860
Citing Fields of Research
Human Reproduction
8,270
Reproductive Health
2,436
Obstetrics/Gynecology
628
Cytogenetics
494
Testicular Disorders
482
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
27,525
Articles tracked across the journal lifetime
Indexed publication set
2,798
807 cited publications
Last 12 months
1,442
120.2 publications/month
Open access share
6.7%
96 OA publications in the last year
Leading citing country
United States
1,340 citing publications
Leading citing field
Human Reproduction
8,270 citing publications
Latest tracked publication
14 October 2026
10 recent records available
Coverage & Indexing History
v1n1, 1986-
v1n1, 1986-
Active Coverage
Research Focus & Classification
Indexed Subjects
Human Reproduction
Issuing & Sponsoring Bodies
Contributor
European Society of Human Reproduction and Embryology
Broad Categories
Reproductive Medicine
Human Reproduction
MeSH Descriptors
Embryology
Reproduction
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
02
DOI 10.1093/humrep/deag143
Open DOI
Structured reporting of diagnostic hysteroscopy findings in women with reproductive disorders: an ESGE–ESHRE–IFFS international consensus
STUDY QUESTION: How should the findings of diagnostic hysteroscopy in women with reproductive disorders be reported? SUMMARY ANSWER: This collaborative document by the European Society for Gynaecological Endoscopy (ESGE), the ESHRE, and ...
03
DOI 10.1093/humrep/deag161
Open DOI
Conception methods and perinatal outcomes among women with kidney disorders: an Australian population-based cohort study
STUDY QUESTION: Do conception methods and related pregnancy outcomes differ between women with and without kidney disease? SUMMARY ANSWER: In this cohort, 3.3% of births among women with kidney disorders were conceived using ART, 1.9% we...
04
DOI 10.1093/humrep/deag160
Open DOI
FSP1+ stromal cell-associated macrophage efferocytosis contributes to impaired decidualization in adenomyosis
STUDY QUESTION: Does disrupted cell crosstalk contribute to embryo implantation failure in adenomyosis, and what is the underlying molecular mechanism? SUMMARY ANSWER: Expanded Fibroblast-Specific Protein 1 (FSP1)+ stromal cell populatio...
05
DOI 10.1093/humrep/deag156
Open DOI
Ovarian reserve after chemotherapy in premenopausal women with breast cancer undergoing fertility preservation counselling with and without unilateral ovarian tissue cryopreservation
STUDY QUESTION: What is the impact of chemotherapy on the ovarian reserve in premenopausal women diagnosed with breast cancer, and how is this impacted by fertility preservation (FP) strategy and age at diagnosis? SUMMARY ANSWER: Chemoth...
06
DOI 10.1093/humrep/deag159
Open DOI
Advanced paternal age affects miscarriages and live birth outcomes in oocyte donation cycles
STUDY QUESTION: Does advanced paternal age affect miscarriage and/or live birth outcomes following the first transfer attempt in oocyte donation cycles? SUMMARY ANSWER: Paternal age has a gradual but cumulative effect that becomes appare...
07
DOI 10.1093/humrep/deag155
Open DOI
Planned egg freezing over 15 years: return to treatment and success rates in Australia and New Zealand
STUDY QUESTION: What are the characteristics and treatment outcomes of women who undertook planned egg freezing (PEF) in Australia and New Zealand between 2009 and 2023? SUMMARY ANSWER: There has been an average year-on-year increase in ...
08
DOI 10.1093/humrep/deag147
Open DOI
L26/O-014 Inositol supplementation in polycystic ovary syndrome (PCOS): a systematic review of randomised controlled trial focusing on data integrity
Study question: Are randomised controlled trials (RCTs) evaluating inositol for polycystic ovary syndrome (PCOS) methodologically trustworthy, and does excluding untrustworthy studies alter reported treatment effects? Summary answer: Thr...
09
DOI 10.1093/humrep/deag157
Open DOI
Infertility and inequality: a plea for action
The recent global guidelines from the World Health Organization on diagnosis, prevention, and treatment of infertility invites us to consider infertility beyond the traditional framing as a clinical condition, recognizing it as a profoun...
10
Bibliographical & Catalog Notes
Title from cover.
Table of contents and abstracts, instructions to authors, subscription and other information available via the Internet.
Supplements accompany some vols.
Also issued online.
Also issued on microfiche and microfilm by University Microfilms Inc.
Issues for Mar.-Oct. 1995 include: Molecular human reproduction, v. 1, no. 1-8, later issued separately, 1996- .